Management of critical COVID-19 Advanced non-invasive respiratory support: high-flow nasal oxygen and non-invasive ventilation- Part 1 – World Health Organization

Overview

WHO recommends prompt recognition of progressive acute hypoxaemic respiratory
failure when a patient with respiratory distress is failing to respond to standard
oxygen therapy and adequate preparation to provide advanced oxygen/ventilatory
support.

Hypoxaemic respiratory failure in ARDS commonly results from intrapulmonary
ventilation-perfusion mismatch or shunt and usually requires mechanical ventilation.

At any time, if there are urgent or emergent indications for intubation, do not delay.

WHO suggests that hospitalized patients with severe or critical COVID-19 with acute
hypoxaemic respiratory failure that do not require emergent intubation be treated
with HFNO, or CPAP or NIV (BiPAP) rather than standard oxygen therapy.

Source